Your shopping cart is currently empty

PPACK Dihydrochloride is an efficient and selective irreversible thrombin inhibitor, which is often used in anticoagulant research, and can be used as a substitute anticoagulant for heparin lithium in blood gas and whole blood electrolyte analysis. PPACK is also used to regulate serine protease-related processes, which has application value in the study of thrombosis and fibrinolysis-related mechanisms.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 mg | $468 | 3-6 months | 3-6 months |
| Description | PPACK Dihydrochloride is an efficient and selective irreversible thrombin inhibitor, which is often used in anticoagulant research, and can be used as a substitute anticoagulant for heparin lithium in blood gas and whole blood electrolyte analysis. PPACK is also used to regulate serine protease-related processes, which has application value in the study of thrombosis and fibrinolysis-related mechanisms. |
| In vitro | PPACK Dihydrochloride can effectively inhibit thrombin, and its Ki value is 3.7 × 10-8 M[2]. PPACK Dihydrochloride (0.2 mM; 2 h coincubation, 12 h measurement) can reduce the permeability increase induced by plasmin in the confluent bovine aortic endothelial cell monolayer by 59% at 12 hours after the initial exposure of plasmin, and completely inhibit the activity of plasmin [3]. PPACK Dihydrochloride (0.2 mM; 4 h post plasmin treatment can alleviate the morphological damage of confluent bovine aortic endothelial cells induced by plasmin, including reducing intercellular space and maintaining the stress fiber structure of F-actin, which was detected after 4 hours of initial plasmin treatment [3]. |
| In vivo | PPACK Dihydrochloride (0.05-0.5 mg/kg; i.v.; Single bolus injection) plays a significant and dose-dependent antithrombotic role in the rat mesenteric microthrombosis model induced by He-Ne laser. Its minimum effective dose to arterioles and venules is 0.1 mg/kg, and it reaches its maximum activity immediately after a single intravenous injection, and the activity can be maintained for 60 minutes[2]. |
| Synonyms | Pebac dihydrochloride, D-Phe-Pro-Arg-CH2Cl 2HCl, D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone dihydrochloride |
| Molecular Weight | 523.88 |
| Formula | C21H33Cl3N6O3 |
| Cas No. | 82188-90-7 |
| Smiles | N=C(N)NCCC[C@@H](C(CCl)=O)NC([C@H]1N(CCC1)C([C@H](N)CC2=CC=CC=C2)=O)=O.Cl.Cl |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100.00 mg/mL (190.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.